ArticleDiabetology & metabolic syndrome2023

Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study.

Yuriko Hajika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.